Single cell technologies are opening new frontiers in biological discovery, enabling researchers to investigate complex systems with unprecedented precision and scale. In this session, Dr. Sam Van de Velde (Salk Institute) will present his latest findings on the sustained genomic response to the GLP-1 agonist Exendin-4 in pancreatic beta cells, highlighting a multi-omics strategy that reveals phosphorylation of Med14 by PKA as a key signaling event in transcriptional activation.
